bendamustine hydrochloride has been researched along with aprepitant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akashi, K; Hosohata, K; Ikesue, H; Kato, K; Makihara, Y; Miyamoto, T; Mori, Y; Nakamura, T; Shiratsuchi, M; Suetsugu, K; Uchida, M | 1 |
| Masuda, S; Uchida, M; Watanabe, H | 1 |
1 review(s) available for bendamustine hydrochloride and aprepitant
| Article | Year |
|---|---|
[Clinical Pharmacology Research for Promoting Individualized Cancer Chemotherapy].
Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Bendamustine Hydrochloride; Dose-Response Relationship, Drug; Humans; Injections, Intravenous; Nausea; Neoplasms; Pharmacology, Clinical; Precision Medicine; Quality of Health Care; Research | 2019 |
1 other study(ies) available for bendamustine hydrochloride and aprepitant
| Article | Year |
|---|---|
Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy.
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Bendamustine Hydrochloride; Dexamethasone; Female; Granisetron; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Palonosetron; Retrospective Studies; Vomiting | 2018 |